Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Cold plasma treatment for hair loss was well tolerated and showed improvement in most patients.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Bimatoprost gel makes eyelashes grow longer, but may cause side effects and should be monitored by an eye doctor.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Bimatoprost may help treat hair loss from alopecia areata.

Cacumen Platycladi extract can safely and effectively reduce hair loss and increase hair density.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Applying pseudoceramide improved skin and hair health.